Figure 4
Figure 4. Loss of miRNAs leads to induction of apoptosis in T-ALL cells. (A) Experimental strategy to study Dicer1 deletion in vitro. CreERT was activated in the CreERT transgenic murine T-ALL cell line M295CreERT (Dicer1lox/lox) for 3 days by addition of tamoxifen (4-OHT) to inactivate Dicer1. Control T-ALL cells (M295CreERT) were treated with ethanol (Et-OH) only. T-ALL cells were passaged twice (P1, P2), maintained under 4-OHT-free conditions, and Dicer1 deletion was assessed by deletion PCR. (B) Dicer1 deletion PCRs on T-ALL cell line M295CreERT after initial deletion of Dicer1 in vitro as outlined in panel A. Shown is 1 representative out of 2 performed experiments. Initial deletion after 3 days of 4-OHT treatment (left). Dicer1 deletion at day 0, 3 (P1, passage 1) and 7 (P2, passage 2) after initial CreERT activation (right). (C) Experimental strategy to lineage trace Dicer1-deficient T-ALL cell populations. Both T-ALL cell lines M295 (parental) and M295CreERT were lentivirally transduced with a loxP flanked eGFP reporter construct (M295CreERT-GFPlox). After administration of 4-OHT for 3 days, parental GFP expressing (GFPhi) and CreERT transgenic GFPlox transduced GFP positive and negative (ΔMIX, GFPhi and GFPlo) cells were assessed by FACS for cell cycle analysis and induction of apoptosis. (D) Representative flow cytometric analysis of M295CreERT-GFPlox 3 days after 4-OHT treatment compared with parental M295-GFPlox T-ALL cells. (E) Representative Dicer1 deletion PCR on DNA derived from parental M295-GFPlox (par.), unsorted M295CreERT-GFPlox (CreERT MIX) and FACS-sorted GFPhi vs GFPlo (CreERT-GFPhi vs CreERT-GFPlo) cells 3 days after 4-OHT treatment. (F) Assessment of cell cycle status of GFPlox transduced T-ALL cells 3 days after 4-OHT treatment (M295-GFPhi parental vs M295CreERT-GFPhi vs M295CreERT-GFPlo). (G) Quantification of early apoptosis (7-AAD− Annexin-V+) in M295-GFPlox (parental GFPhi) and M295CreERT-GFPhi vs M295CreERT-GFPlo cells. Data (F-G) are pooled from 2 independent experiments. (H) Experimental approach to assess the fate of Dicer1-deleted T-ALL cells in vivo. M295CreERT cells were treated for 3 days with 4-OHT yielding deleted and undeleted cells (ΔMIX) or Et-OH only as control (CTR), these cells were subsequently transplanted into RAG2γc−/− recipient animals. (I) Kaplan-Meier survival plot of RAG2γc−/− recipients receiving M295CreERT CTR T-ALL cells or ΔMIX cells. The dashed line indicates MST: red = 16 days, green = 20.5 days. (J) Dicer1 deletion PCR on DNA from cells of the M295CreERT T-ALL line prior to transplantation (CTR or ΔMIX, upper panel, “input”, same experiment as in panel I) and on splenocytes of RAG2γc−/− recipient animals with late-stage T-ALL (lower panel).

Loss of miRNAs leads to induction of apoptosis in T-ALL cells. (A) Experimental strategy to study Dicer1 deletion in vitro. CreERT was activated in the CreERT transgenic murine T-ALL cell line M295CreERT (Dicer1lox/lox) for 3 days by addition of tamoxifen (4-OHT) to inactivate Dicer1. Control T-ALL cells (M295CreERT) were treated with ethanol (Et-OH) only. T-ALL cells were passaged twice (P1, P2), maintained under 4-OHT-free conditions, and Dicer1 deletion was assessed by deletion PCR. (B) Dicer1 deletion PCRs on T-ALL cell line M295CreERT after initial deletion of Dicer1 in vitro as outlined in panel A. Shown is 1 representative out of 2 performed experiments. Initial deletion after 3 days of 4-OHT treatment (left). Dicer1 deletion at day 0, 3 (P1, passage 1) and 7 (P2, passage 2) after initial CreERT activation (right). (C) Experimental strategy to lineage trace Dicer1-deficient T-ALL cell populations. Both T-ALL cell lines M295 (parental) and M295CreERT were lentivirally transduced with a loxP flanked eGFP reporter construct (M295CreERT-GFPlox). After administration of 4-OHT for 3 days, parental GFP expressing (GFPhi) and CreERT transgenic GFPlox transduced GFP positive and negative (ΔMIX, GFPhi and GFPlo) cells were assessed by FACS for cell cycle analysis and induction of apoptosis. (D) Representative flow cytometric analysis of M295CreERT-GFPlox 3 days after 4-OHT treatment compared with parental M295-GFPlox T-ALL cells. (E) Representative Dicer1 deletion PCR on DNA derived from parental M295-GFPlox (par.), unsorted M295CreERT-GFPlox (CreERT MIX) and FACS-sorted GFPhi vs GFPlo (CreERT-GFPhi vs CreERT-GFPlo) cells 3 days after 4-OHT treatment. (F) Assessment of cell cycle status of GFPlox transduced T-ALL cells 3 days after 4-OHT treatment (M295-GFPhi parental vs M295CreERT-GFPhi vs M295CreERT-GFPlo). (G) Quantification of early apoptosis (7-AAD Annexin-V+) in M295-GFPlox (parental GFPhi) and M295CreERT-GFPhi vs M295CreERT-GFPlo cells. Data (F-G) are pooled from 2 independent experiments. (H) Experimental approach to assess the fate of Dicer1-deleted T-ALL cells in vivo. M295CreERT cells were treated for 3 days with 4-OHT yielding deleted and undeleted cells (ΔMIX) or Et-OH only as control (CTR), these cells were subsequently transplanted into RAG2γc−/− recipient animals. (I) Kaplan-Meier survival plot of RAG2γc−/− recipients receiving M295CreERT CTR T-ALL cells or ΔMIX cells. The dashed line indicates MST: red = 16 days, green = 20.5 days. (J) Dicer1 deletion PCR on DNA from cells of the M295CreERT T-ALL line prior to transplantation (CTR or ΔMIX, upper panel, “input”, same experiment as in panel I) and on splenocytes of RAG2γc−/− recipient animals with late-stage T-ALL (lower panel).

Close Modal

or Create an Account

Close Modal
Close Modal